Taking Lessons From Hematology Experts in Tampa

Article

We headed to Tampa, Florida for a State of the Science Summit on Hematologic Malignancies. The meeting covered updates in follicular lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, multiple myeloma, acute lymphoblastic leukemia, chronic myeloid leukemia, acute myeloid leukemia, myeloproliferative neoplasms, and CAR T-cell therapy.

We headed to Tampa, Florida for a State of the Science Summit on Hematologic Malignancies. The meeting covered updates in follicular lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, multiple myeloma, acute lymphoblastic leukemia, chronic myeloid leukemia, acute myeloid leukemia, myeloproliferative neoplasms, and CAR T-cell therapy.

Related Videos
Alfonso Sabater, MD, PhD, on Bringing Gene Therapy to Ophthalmology
Sharon Hesterlee, PhD
Thomas Crawford, MD, on Helping Patients With SMA Left Behind by Gene Therapy
J. Andrew Livingston, MD
Shankar Musunuri, PhD
Related Content
Around the Helix: Cell and Gene Therapy Company Updates – November 29, 2023

Around the Helix: Cell and Gene Therapy Company Updates – November 29, 2023

November 29th 2023
Article

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Autolus Submits Obe-Cel BLA for Adult B-ALL

Autolus Submits Obe-Cel BLA for Adult R/R B-ALL

November 29th 2023
Article

The company also plans to submit an MAA to the EMA in the first half of 2024.

FDA to Investigate Risk of T-Cell Malignancy After CAR T-Cell Therapy

FDA to Investigate Risk of T-Cell Malignancy After CAR T-Cell Therapy

November 28th 2023
Article

The FDA has received reports of multiple T-cell malignancies in patients after approved CAR-T treatment.

Second Gene Therapy for Epidermolysis Bullosa up for Review

Second Gene Therapy for Epidermolysis Bullosa up for Priority Review

November 28th 2023
Article

Pz-cel has a PDUFA date of May 25, 2024.

Nexcella’s Light Chain Amyloidosis CAR-T NXC-201 Expands Clinical Trial Activities Into the US

Nexcella’s Light Chain Amyloidosis CAR-T NXC-201 Expands Clinical Trial Activities Into the US

November 28th 2023
Article

The CAR-T was already being assessed in the ongoing phase 1a/1b NEXICART-1 clinical trial in Israel ahead of this IND clearance by the FDA.

Gracell’s CAR T-Cell Therapy to be Evaluated in Lupus

Gracell’s CAR T-Cell Therapy to be Evaluated in Lupus

November 28th 2023
Article

GC012F recently yielded a 100% ORR in an investigator-initiated trial in patients with newly diagnosed multiple myeloma.

© 2023 MJH Life Sciences

All rights reserved.